+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 8bi7 | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Binary structure of 14-3-3s and PKR phosphopeptide | ||||||
要素 |
| ||||||
キーワード | PEPTIDE BINDING PROTEIN / 14-3-3 / hub-protein / phosphopeptide | ||||||
| 機能・相同性 | 機能・相同性情報Inhibition of PKR / regulation of NLRP3 inflammasome complex assembly / eukaryotic translation initiation factor 2alpha kinase activity / response to interferon-alpha / negative regulation of osteoblast proliferation / regulation of hematopoietic progenitor cell differentiation / positive regulation of stress-activated MAPK cascade / protein phosphatase regulator activity / SUMOylation of immune response proteins / regulation of hematopoietic stem cell proliferation ...Inhibition of PKR / regulation of NLRP3 inflammasome complex assembly / eukaryotic translation initiation factor 2alpha kinase activity / response to interferon-alpha / negative regulation of osteoblast proliferation / regulation of hematopoietic progenitor cell differentiation / positive regulation of stress-activated MAPK cascade / protein phosphatase regulator activity / SUMOylation of immune response proteins / regulation of hematopoietic stem cell proliferation / regulation of hematopoietic stem cell differentiation / regulation of translational initiation / negative regulation of viral genome replication / regulation of epidermal cell division / protein kinase C inhibitor activity / positive regulation of epidermal cell differentiation / keratinocyte development / keratinization / regulation of cell-cell adhesion / cAMP/PKA signal transduction / Regulation of localization of FOXO transcription factors / keratinocyte proliferation / phosphoserine residue binding / Activation of BAD and translocation to mitochondria / negative regulation of keratinocyte proliferation / establishment of skin barrier / negative regulation of protein localization to plasma membrane / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / negative regulation of protein kinase activity / negative regulation of stem cell proliferation / endoplasmic reticulum unfolded protein response / positive regulation of chemokine production / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / RHO GTPases activate PKNs / positive regulation of protein localization / antiviral innate immune response / positive regulation of cell adhesion / cellular response to amino acid starvation / protein sequestering activity / protein export from nucleus / negative regulation of innate immune response / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / release of cytochrome c from mitochondria / positive regulation of cytokine production / positive regulation of protein export from nucleus / stem cell proliferation / TP53 Regulates Metabolic Genes / non-membrane spanning protein tyrosine kinase activity / Translocation of SLC2A4 (GLUT4) to the plasma membrane / non-specific protein-tyrosine kinase / positive regulation of non-canonical NF-kappaB signal transduction / positive regulation of NF-kappaB transcription factor activity / PKR-mediated signaling / Evasion by RSV of host interferon responses / ISG15 antiviral mechanism / response to virus / intrinsic apoptotic signaling pathway in response to DNA damage / Interferon alpha/beta signaling / kinase activity / intracellular protein localization / double-stranded RNA binding / regulation of protein localization / protein autophosphorylation / positive regulation of cell growth / defense response to virus / protein phosphorylation / non-specific serine/threonine protein kinase / protein kinase activity / regulation of cell cycle / negative regulation of translation / positive regulation of MAPK cascade / ribosome / cadherin binding / translation / negative regulation of cell population proliferation / protein serine kinase activity / protein serine/threonine kinase activity / protein kinase binding / negative regulation of apoptotic process / perinuclear region of cytoplasm / negative regulation of transcription by RNA polymerase II / signal transduction / extracellular space / RNA binding / extracellular exosome / nucleoplasm / ATP binding / identical protein binding / nucleus / membrane / cytoplasm / cytosol 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 1.4 Å | ||||||
データ登録者 | Somsen, B.A. / Ottmann, C. | ||||||
| 資金援助 | オランダ, 1件
| ||||||
引用 | ジャーナル: J.Am.Chem.Soc. / 年: 2023タイトル: Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERR gamma Protein-Protein Interaction as a Molecular Glue Drug Discovery Approach. 著者: Somsen, B.A. / Schellekens, R.J.C. / Verhoef, C.J.A. / Arkin, M.R. / Ottmann, C. / Cossar, P.J. / Brunsveld, L. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 8bi7.cif.gz | 74.5 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb8bi7.ent.gz | 52.7 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 8bi7.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 8bi7_validation.pdf.gz | 433.8 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 8bi7_full_validation.pdf.gz | 434.2 KB | 表示 | |
| XML形式データ | 8bi7_validation.xml.gz | 14.3 KB | 表示 | |
| CIF形式データ | 8bi7_validation.cif.gz | 22.1 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/bi/8bi7 ftp://data.pdbj.org/pub/pdb/validation_reports/bi/8bi7 | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 8b2iC ![]() 8b2kC ![]() 8b4qC ![]() 8b5pC ![]() 8bfcC ![]() 8bjgC ![]() 8bjnC ![]() 8bm5C ![]() 6y1dS S: 精密化の開始モデル C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 単位格子 |
| ||||||||
| Components on special symmetry positions |
|
-
要素
| #1: タンパク質 | 分子量: 26542.914 Da / 分子数: 1 / 由来タイプ: 組換発現 詳細: GAMGS at the beginning (-5 to -1) are part of the expression tag 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: SFN, HME1 / 発現宿主: ![]() | ||||||
|---|---|---|---|---|---|---|---|
| #2: タンパク質・ペプチド | 分子量: 1412.465 Da / 分子数: 1 / 由来タイプ: 合成 / 由来: (合成) Homo sapiens (ヒト)参照: UniProt: P19525, non-specific serine/threonine protein kinase, non-specific protein-tyrosine kinase | ||||||
| #3: 化合物 | ChemComp-MG / #4: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | N | Has protein modification | Y | |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.66 Å3/Da / 溶媒含有率: 53.82 % |
|---|---|
| 結晶化 | 温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 詳細: 0.095 M Hepes pH 7.1, 0.19 M CaCl2, 25% PEG400, 5% glycerol |
-データ収集
| 回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: PETRA III, DESY / ビームライン: P11 / 波長: 1.0332 Å |
| 検出器 | タイプ: DECTRIS EIGER X 16M / 検出器: PIXEL / 日付: 2022年4月6日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.0332 Å / 相対比: 1 |
| 反射 | 解像度: 1.4→45.64 Å / Num. obs: 742644 / % possible obs: 99.7 % / 冗長度: 12.9 % / CC1/2: 0.999 / Net I/σ(I): 36.4 |
| 反射 シェル | 解像度: 1.4→1.43 Å / Mean I/σ(I) obs: 7.1 / Num. unique obs: 33081 / CC1/2: 0.984 |
-
解析
| ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: 6y1d 解像度: 1.4→45.64 Å / SU ML: 0.12 / 交差検証法: THROUGHOUT / σ(F): 1.33 / 位相誤差: 17.44 / 立体化学のターゲット値: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.1 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 1.4→45.64 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル |
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
オランダ, 1件
引用








PDBj

















